Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 12;7(3):FSO643.
doi: 10.2144/fsoa-2020-0154.

Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study

Affiliations
Review

Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study

Giovanni Tarantino et al. Future Sci OA. .

Abstract

Background: Since prostate-specific antigen (PSA) levels can be influenced by some routinely available clinical factors, a retrospective study was conducted to explore the influence of obesity, smoking habit, heavy drinking and chronic obstructive pulmonary disease on PSA levels in men with histologically confirmed prostate cancer.

Patients & methods: We reviewed the medical records of 833 prostate cancer patients undergoing radical prostatectomy.

Results: Serum PSA levels at the time of surgery were not associated with either BMI or history of chronic obstructive pulmonary disease or heavy drinking. Conversely, PSA levels were associated with smoking status.

Conclusion: Among the clinical factors explored in this homogeneous population, only tobacco use was associated with PSA levels, which should be considered when using PSA-based screening in male smokers.

Keywords: BMI; COPD; Gleason score; heavy drinking; smoking habit; total PSA.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

Figures

Figure 1.
Figure 1.. Distribution of total prostate-specific antigen levels according to BMI.
The flat regression line indicates no statistical significance. PSA: Prostate-specific antigen.

References

    1. Ferro M, Terracciano D, Buonerba C et al. The emerging role of obesity, diet and lipid metabolism in prostate cancer. Future Oncol. 13(3), 285–293 (2017). - PMC - PubMed
    1. Rescigno P, Buonerba C, Bellmunt J, Sonpavde G, De Placido S, Di Lorenzo G New perspectives in the therapy of castration resistant prostate cancer. Curr. Drug Targets 13(13), 1676–1686 (2012). - PubMed
    1. Buonerba C, Ferro M, Dolce P et al. Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis. Crit. Rev. Oncol. Hematol. 151, 102992 (2020). - PubMed
    1. Ceylan C, Gazel E, Keleş İ, Doluoğlu Ö, Yığman M Can the free/total PSA ratio predict the Gleason score before prostate biopsy? Curr. Urol. 9(1), 24–27 (2016). - PMC - PubMed
    1. Wan X, Yang C Dosage of prostate specific antigen in prostate cancer diagnosis and follow-up. J. Genitourinary Res. Pract. 1(1), 16–22 (2019).

LinkOut - more resources